Levetiracetam (Epictal (500 mg)) is an anticonvulsant, prescribed for partial seizures. It works by reducing the activity in the brain. It can be used alone or with other antiepileptic medications.

UCB today announced findings from new studies of the once-daily antiepileptic drug (AED) Keppra XR™ (levetiracetam) extended-release tablets comparing tolerability vs. levetiracetam immediate release ...

Am J Health Syst Pharm. 2009;66(6):541-561. Shorvon et al. [20] conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and tolerability of levetiracetam ...

Product Overwrap Description - Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 mL) (Photo: Business Wire) Product Infusion Bag Primary Description with ...

ROCKVILLE, Md. The Food and Drug Administration has approved a generic version of UBC's Keppra, agency records show. The agency approved Solco Healthcare's generic levetiracetam tablets in the 250-mg, ...

July 22, 2002 — Unlike many antiepileptic drugs (AEDs) that alter the effectiveness of oral contraceptive pills (OCP), primarily through induction of the CYP 3A4 enzyme system, levetiracetam (Keppra) ...

Valproate (Depakene) emerged as the best first-line choice for generalized epilepsy in a pragmatic study and lamotrigine (Lamictal) as the best first-line treatment for focal epilepsy, British ...

ATLANTA, Dec. 3 /PRNewswire/ -- UCB today announced results of a Phase III trial demonstrating that its antiepileptic drug (AED) in development Keppra XR(TM) (levetiracetam) extended-release tablets ...

PITTSBURGH, Dec. 11 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the ...

March 04, 2015, Mumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) (Reuters: SPRC.BO, Bloomberg: SPADV IN, NSE: SPARC, BSE: 532872) today announced that the U.S. Food and Drug Administration ...